Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Post-conflict acute stress reactions in Kazakhstan in the aftermath of January 2022 unrests: A national survey.
Glushkova N, Ivankov A, Trenina V, Oshibayeva A, Kalmatayeva Z, Temirbekova Z, Mamyrbekova S, Davletov K, Khismetova Z, Kauysheva A, Auyezova A, Zhanaspayev M, Pivina L, Koshmaganbetova G, Nurbakyt A, Sarsenbayeva G, Sadibekova Z, Gazaliyeva M, Kulimbet M, Kalmatayeva D, Zhylkybekova A, Nurgaliyeva Z, Sultanbekov K, Semenov D, Izmailovich M, Tsigengagel O, Munir K. Glushkova N, et al. Among authors: sarsenbayeva g. Heliyon. 2023 Oct 21;9(11):e21065. doi: 10.1016/j.heliyon.2023.e21065. eCollection 2023 Nov. Heliyon. 2023. PMID: 37964844 Free PMC article.
Features of the Development of a Mobile Application for Cardiac Patients.
Turgambayeva A, Kulbayeva S, Sadibekova Z, Tursynbekova A, Sarsenbayeva G, Zhanaliyeva M, Zhakupova T. Turgambayeva A, et al. Among authors: sarsenbayeva g. Acta Inform Med. 2022 Dec;30(4):302-307. doi: 10.5455/aim.2022.30.302-307. Acta Inform Med. 2022. PMID: 36467326 Free PMC article.
Efficacy and safety of an inactivated whole-virion vaccine against COVID-19, QazCovid-in®, in healthy adults: A multicentre, randomised, single-blind, placebo-controlled phase 3 clinical trial with a 6-month follow-up.
Khairullin B, Zakarya K, Orynbayev M, Abduraimov Y, Kassenov M, Sarsenbayeva G, Sultankulova K, Chervyakova O, Myrzakhmetova B, Nakhanov A, Nurpeisova A, Zhugunissov K, Assanzhanova N, Nurabayev S, Kerimbayev A, Yershebulov Z, Burashev Y, Kulmagambetov I, Davlyatshin T, Sergeeva M, Buzitskaya Z, Stukova M, Kutumbetov L. Khairullin B, et al. Among authors: sarsenbayeva g. EClinicalMedicine. 2022 Jun 25;50:101526. doi: 10.1016/j.eclinm.2022.101526. eCollection 2022 Aug. EClinicalMedicine. 2022. PMID: 35770251 Free PMC article.
Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan.
Zakarya K, Kutumbetov L, Orynbayev M, Abduraimov Y, Sultankulova K, Kassenov M, Sarsenbayeva G, Kulmagambetov I, Davlyatshin T, Sergeeva M, Stukova M, Khairullin B. Zakarya K, et al. Among authors: sarsenbayeva g. EClinicalMedicine. 2021 Sep;39:101078. doi: 10.1016/j.eclinm.2021.101078. Epub 2021 Aug 14. EClinicalMedicine. 2021. PMID: 34414368 Free PMC article.
Safety and immunogenicity of trivalent inactivated influenza vaccine in adults 60 years of age and older: a phase II, a randomized, comparative trial in Kazakhstan.
Sarsenbayeva G, Issagulov T, Kassenov M, Abitay R, Orynbayev M, Stukova M, Pisareva M, Davlyatshin T, Lespek K, Khairullin B. Sarsenbayeva G, et al. Hum Vaccin Immunother. 2020 Aug 2;16(8):1791-1797. doi: 10.1080/21645515.2019.1705691. Epub 2020 Feb 12. Hum Vaccin Immunother. 2020. PMID: 32048890 Free PMC article. Clinical Trial.
Immunogenicity and safety of a novel seasonal influenza preservative-free vaccine manufactured in Kazakhstan: Results of a randomized, comparative, phase II clinical trial in adults.
Sarsenbayeva G, Volgin Y, Kassenov M, Issagulov T, Bogdanov N, Sansyzbay A, Stukova M, Buzitskaya Z, Кulmagambetov I, Davlyatshin T, Khairullin B. Sarsenbayeva G, et al. Hum Vaccin Immunother. 2018 Mar 4;14(3):609-614. doi: 10.1080/21645515.2017.1387345. Epub 2017 Dec 12. Hum Vaccin Immunother. 2018. PMID: 29112488 Free PMC article. Clinical Trial.
Safety and immunogenicity of the novel seasonal preservative- and adjuvant-free influenza vaccine: Blind, randomized, and placebo-controlled trial.
Sarsenbayeva G, Volgin Y, Kassenov M, Issagulov T, Bogdanov N, Sansyzbay A, Abitay R, Nurpeisova A, Sagymbay A, Koshemetov Z, Stukova M, Buzitskaya Z, Кulmagambetov I, Karabayeva D, Davlyatshin T, Khairullin B. Sarsenbayeva G, et al. J Med Virol. 2018 Jan;90(1):41-49. doi: 10.1002/jmv.24922. Epub 2017 Sep 25. J Med Virol. 2018. PMID: 28842994 Clinical Trial.
11 results